Swabbing your saliva with home DNA kits could lead to more than finding out your own ancestral breakdown. Announced on July 25, 23andMe has received a $300 million investment from GlaxoSmithKline, the sixth largest pharmaceutical company in the world. The four-year deal will give GlaxoSmithKline (GSK) access to 23andM
Source: Read Full Article